Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:16 PM UTC
| NCT Number | NCT07562152 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | PHASE3 |
| Target Enrollment | 510 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Immuneering Corporation |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07562152 is currently recruiting participants. This phase3 study for pancreatic cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by Immuneering Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07562152 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07562152 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.